FULC Competitors & Alternatives
Compare Fulcrum Therapeutics Inc with similar stocks in the same industry
Biotechnology
FULC
Main Stock$3.68
Tradestie Score
52
Market Cap
$504.67M
Revenue Growth
-1.0%
Analyst Upside
-0.4%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.59
|
$307.12M | - | 63 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.38
|
$304.12M | - | 59 | Compare |
|
ALEC
Alector, Inc. Common Stock
|
$1.83
|
$303.64M | - | 50 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$14.91
|
$297.23M | - | 41 | Compare |
|
OMER
Omeros Corporation
|
$16.86
|
$281.75M | 13.6 | 60 | Compare |
|
DBVT
DBV Technologies S.A.
|
$9.68
|
$275.54M | - | 63 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.94
|
$269.08M | 0.1 | 64 | Compare |
|
PBYI
PUMA BIOTECHNOLOGY INC
|
$11.26
|
$265.45M | 21.0 | 46 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$24.28
|
$256.54M | - | 53 | Compare |
More FULC Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry